EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Features, Genetics and Treatment in a Russian Cohort of Young Patients with Xeroderma Pigmentosum: A Single Center Experience

Tatiana Belysheva iD, Tatiana Nasedkina iD, Ekaterina Zelenova iD, Vera Semenova, Peter Sparber iD, Elena Sharapova, Denis Sofronov, Marina Dorofeeva, Olga Bozhko, Yana Vishnevskaya, Irina Kletskaya iD, Svetlana Mikhaylova und 5 weitere

International Journal of Molecular Sciences · 04.11.2026 · 27 (21) · 9889

DOI: 10.3390/ijms27219889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.11.2026. Verfasst von Tatiana Belysheva und 16 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia. Hauptthemen laut MEDLINE: Xeroderma Pigmentosum. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are rare autosomal recessive DNA repair disorders. XP is characterized by extreme sensitivity to UV radiation and a very high risk of skin cancer. To date, little is known about the clinical characteristics and genetic basis of these diseases in Russia. Here, we present a detailed study of 14 patients (aged 6–30 years) from 11 unrelated families of diverse ethnic backgrounds. Using a multigene panel or whole-genome sequencing, we identified patients with homozygous or compound heterozygous variants in XPC (n = 8), XPA (n = 4), DDB2 (n = 1), and ERCC6 (n = 1). Two XP and one CS cases were presented in one family. A total of 110 relatives were screened to determine carrier status. Skin cancer was revealed in 100% of the 13 XP patients; the median age at first manifestation was 13 years (range 5–23). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma developed in 10, 7, and 3 patients, respectively. All three cancer types occurred in two patients. The patients underwent surgical treatment; additionally, two patients with BCC received targeted therapy (vismodegib, sonidegib). Anti-PD-1 immunotherapy was administered successfully in three patients with multiple or advanced skin tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xeroderma PigmentosumHumansAdolescentChildFemaleMaleYoung AdultAdultSkin NeoplasmsDNA-Binding ProteinsRussiaBasal Cell CarcinomaXeroderma Pigmentosum Group A ProteinCockayne SyndromePoly-ADP-Ribose Binding ProteinsCarcinoma, Squamous Cell

Stichwörter der Autor:innen

DDB2ERCC6XPAXPCbasal cell carcinomamelanomapembrolizumabsonidegibsquamous cell carcinomavismodegibxeroderma pigmentosum

Substanzen

DNA-Binding ProteinsXPC protein, humanXeroderma Pigmentosum Group A ProteinXPA protein, humanDDB2 protein, humanPoly-ADP-Ribose Binding Proteins

Autor:innen und Institutionen

  • N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
  • Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 119991 Moscow, Russia.
  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 117198 Moscow, Russia.
  • Research Center for Medical Genetics, 115522 Moscow, Russia.
  • Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery, Pirogov Russian National Research Medical University, 125412 Moscow, Russia.
  • Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, 119571 Moscow, Russia.

ORCID-Profile: Tatiana Belysheva, Tatiana Nasedkina, Ekaterina Zelenova, Peter Sparber, Irina Kletskaya, Timur Valiev, Kristina Orlova

Förderung

  • Ministry of Health of the Russian Federation

Zitieren

APA

Belysheva, T., Nasedkina, T., Zelenova, E., Semenova, V., Sparber, P., Sharapova, E., Sofronov, D., Dorofeeva, M., Bozhko, O., Vishnevskaya, Y., Kletskaya, I., Mikhaylova, S., Valiev, T., Petenko, N., Orlova, K., Samoilenko, I., & Varfolomeeva, S. (2026). Clinical Features, Genetics and Treatment in a Russian Cohort of Young Patients with Xeroderma Pigmentosum: A Single Center Experience. International Journal of Molecular Sciences, 27(21), 9889. https://doi.org/10.3390/ijms27219889

Vancouver

Belysheva T, Nasedkina T, Zelenova E, Semenova V, Sparber P, Sharapova E, et al. Clinical Features, Genetics and Treatment in a Russian Cohort of Young Patients with Xeroderma Pigmentosum: A Single Center Experience. International Journal of Molecular Sciences. 2026;27(21):9889. doi:10.3390/ijms27219889

BibTeX
@article{Belysheva2026,
  author = {Belysheva, Tatiana and Nasedkina, Tatiana and Zelenova, Ekaterina and Semenova, Vera and Sparber, Peter and Sharapova, Elena and Sofronov, Denis and Dorofeeva, Marina and Bozhko, Olga and Vishnevskaya, Yana and Kletskaya, Irina and Mikhaylova, Svetlana and Valiev, Timur and Petenko, Natalia and Orlova, Kristina and Samoilenko, Igor and Varfolomeeva, Svetlana},
  title = {Clinical Features, Genetics and Treatment in a Russian Cohort of Young Patients with Xeroderma Pigmentosum: A Single Center Experience},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9889},
  doi = {10.3390/ijms27219889}
}
Kostenlos starten →